Physician liability: the next big thing for personalized medicine?
Physician liability: the next big thing for personalized medicine?
复制标题
DOI：
10.2217/pme.11.33
复制
发表时间：
2011-07-01
影响因子：
2.3
通讯作者：
Lindor, Rachel A.
中科院分区：
文献类型：
--
作者：
Marchant, Gary E.;Campos-Outcalt, Doug E.;Lindor, Rachel A.
责任可能是个性化医疗未来方向和实施的主要驱动力，刺激采用基因检测和其他药物基因组学技术，在某些情况下是适当的，在其他情况下是过早的或无效的防御性医疗。虽然个性化医疗链中的所有实体都将面临责任风险，但医生将面临最大的风险，因为他们缺乏防御能力，在处理遗传学方面的经验有限，以及在实施新医疗技术方面的专业差异越来越大。基因检测责任的历史，主要是在产前检测的背景下，表明责任往往是不可预测的，并在不断变化的医疗实践中产生影响。至关重要的是，要以积极主动的方式预测和尝试预防此类责任风险，以尽量减少责任可能造成的破坏性影响。
Liability is likely to be a major driver for the future direction and implementation of personalized medicine, spurring the adoption of genetic tests and other pharmacogenomic technologies, in some cases appropriately, and in other cases prematurely or as inefficient defensive medicine. While all entities in the personalized medicine chain will face liability risks, physicians will be at the greatest risk owing to their lack of defenses, limited experience in dealing with genetics and the growing disparities within the profession in implementing new medical technologies. The history of liability for genetic testing, primarily in the prenatal testing context, suggests that liability will often be both unpredictable and influential in changing medical practice. It is critical to anticipate and attempt to prevent such liability risks in a proactive manner so to minimize the disruptive impact that liability can cause.